Items where the Publication is PHARMACOECONOMICS
Number of items: 6.
2020
  • Correction to: A Systematic Review of Methodological Variation in Healthcare Provider Perspective Tuberculosis Costing Papers Conducted in Low- and Middle-Income Settings, Using An Intervention-Standardised Unit Cost Typology. (2020) Cunnama, Lucy; Gomez, Gabriela B; Siapka, Mariana; Herzel, Ben; Hill, Jeremy; Kairu, Angela; Levin, Carol; Okello, Dickson; DeCormier Plosky, Willyanne; Garcia Baena, Inés; Sweeney, Sedona; Vassall, Anna; Sinanovic, Edina
  • Comparing the Analysis and Results of a Modified Social Accounting Matrix Framework with Conventional Methods of Reporting Indirect Non-Medical Costs. (2020) Standaert, Baudouin; Sauboin, Christophe; Leclerc, Quentin J; Connolly, Mark P
  • Budget Impact of Oral Semaglutide Intensification versus Sitagliptin among US Patients with Type 2 Diabetes Mellitus Uncontrolled with Metformin. (2020) Wehler, Elizabeth; Lautsch, Dominik; Kowal, Stacey; Davies, Glenn; Briggs, Andrew; Li, Qianyi; Rajpathak, Swapnil; Alsumali, Adnan
    • 2019
  • Estimating Lifetime Benefits Associated with Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival Extrapolations. (2019) Ouwens, Mario JNM; Mukhopadhyay, Pralay; Zhang, Yiduo; Huang, Min; Latimer, Nicholas; Briggs, Andrew
    • 2018
  • Probabilistic Sensitivity Analysis in Cost-Effectiveness Models: Determining Model Convergence in Cohort Models. (2018) Hatswell, Anthony J; Bullement, Ash; Briggs, Andrew; Paulden, Mike; Stevenson, Matthew D
  • A Decision-Analytic Model to Assess the Cost-Effectiveness of Etelcalcetide vs. Cinacalcet. (2018) Stollenwerk, Björn; Iannazzo, Sergio; Akehurst, Ron; Adena, Michael; Briggs, Andrew; Dehmel, Bastian; Parfrey, Patrick; Belozeroff, Vasily